These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 32400077)
21. Two common mutations (p.Gln832X and c.663+1G>C) account for about a third of the DYSF mutations in Korean patients with dysferlinopathy. Park YE; Kim HS; Lee CH; Nam TS; Choi YC; Kim DS Neuromuscul Disord; 2012 Jun; 22(6):505-10. PubMed ID: 22297152 [TBL] [Abstract][Full Text] [Related]
22. Novel five nucleotide deletion in dysferlin leads to autosomal recessive limb-girdle muscular dystrophy. Chen YL; Wu WB; Wang P; Yip PK; Wu YN; Lin YH; Lin WN Physiol Rep; 2023 Dec; 11(24):e15887. PubMed ID: 38110300 [TBL] [Abstract][Full Text] [Related]
23. Dysferlin aggregation in limb-girdle muscular dystrophy type 2B/Miyoshi Myopathy necessitates mutational screen for diagnosis [corrected]. Nilsson MI; Laureano ML; Saeed M; Tarnopolsky MA Muscle Nerve; 2013 May; 47(5):740-7. PubMed ID: 23519732 [TBL] [Abstract][Full Text] [Related]
24. Genetically confirmed limb-girdle muscular dystrophy type 2B with DYSF mutation using gene panel sequencing: A case report. Lee SJ; Choi E; Shin S; Park J Medicine (Baltimore); 2020 Jul; 99(28):e20810. PubMed ID: 32664072 [TBL] [Abstract][Full Text] [Related]
26. New aspects on patients affected by dysferlin deficient muscular dystrophy. Klinge L; Aboumousa A; Eagle M; Hudson J; Sarkozy A; Vita G; Charlton R; Roberts M; Straub V; Barresi R; Lochmüller H; Bushby K J Neurol Neurosurg Psychiatry; 2010 Sep; 81(9):946-53. PubMed ID: 19528035 [TBL] [Abstract][Full Text] [Related]
27. Targeted next-generation sequencing for the genetic diagnosis of dysferlinopathy. Shin HY; Jang H; Han JH; Park HJ; Lee JH; Kim SW; Kim SM; Park YE; Kim DS; Bang D; Lee MG; Lee JH; Choi YC Neuromuscul Disord; 2015 Jun; 25(6):502-10. PubMed ID: 25868377 [TBL] [Abstract][Full Text] [Related]
28. An in-frame pseudoexon activation caused by a novel deep-intronic variant in the dysferlin gene. Sun C; Xie Z; Cong L; Xu Y; Liu Z Ann Clin Transl Neurol; 2023 Feb; 10(2):292-296. PubMed ID: 36542547 [TBL] [Abstract][Full Text] [Related]
29. Dysferlinopathy in Iran: Clinical and genetic report. Fatehi F; Nafissi S; Urtizberea JA; Blanck-Labelle V; Lévy N; Krahn M; Dbouk MB; Attarian S J Neurol Sci; 2015 Dec; 359(1-2):256-9. PubMed ID: 26671124 [TBL] [Abstract][Full Text] [Related]
30. Nonsyndromic Early-Onset Cone-Rod Dystrophy and Limb-Girdle Muscular Dystrophy in a Consanguineous Israeli Family are Caused by Two Independent yet Linked Mutations in ALMS1 and DYSF. Lazar CH; Kimchi A; Namburi P; Mutsuddi M; Zelinger L; Beryozkin A; Ben-Simhon S; Obolensky A; Ben-Neriah Z; Argov Z; Pikarsky E; Fellig Y; Marks-Ohana D; Ratnapriya R; Banin E; Sharon D; Swaroop A Hum Mutat; 2015 Sep; 36(9):836-41. PubMed ID: 26077327 [TBL] [Abstract][Full Text] [Related]
31. Whole-exome sequencing identifies novel pathogenic mutations and putative phenotype-influencing variants in Polish limb-girdle muscular dystrophy patients. Fichna JP; Macias A; Piechota M; Korostyński M; Potulska-Chromik A; Redowicz MJ; Zekanowski C Hum Genomics; 2018 Jul; 12(1):34. PubMed ID: 29970176 [TBL] [Abstract][Full Text] [Related]
32. Next-generation sequencing identified a novel DYSF variant in a patient with limb-girdle muscular dystrophy type 2B: A case report. Li Q; Tan C; Chen J; Zhang L Medicine (Baltimore); 2020 Oct; 99(41):e22615. PubMed ID: 33031319 [TBL] [Abstract][Full Text] [Related]
33. Clinical heterogeneity and a high proportion of novel mutations in a Chinese cohort of patients with dysferlinopathy. Xi J; Blandin G; Lu J; Luo S; Zhu W; Béroud C; Pécheux C; Labelle V; Lévy N; Urtizberea JA; Zhao C; Krahn M Neurol India; 2014; 62(6):635-9. PubMed ID: 25591676 [TBL] [Abstract][Full Text] [Related]
34. Analysis of the DYSF mutational spectrum in a large cohort of patients. Krahn M; Béroud C; Labelle V; Nguyen K; Bernard R; Bassez G; Figarella-Branger D; Fernandez C; Bouvenot J; Richard I; Ollagnon-Roman E; Bevilacqua JA; Salvo E; Attarian S; Chapon F; Pellissier JF; Pouget J; Hammouda el H; Laforêt P; Urtizberea JA; Eymard B; Leturcq F; Lévy N Hum Mutat; 2009 Feb; 30(2):E345-75. PubMed ID: 18853459 [TBL] [Abstract][Full Text] [Related]
35. Heterogeneous characteristics of Korean patients with dysferlinopathy. Park HJ; Hong JM; Suh GI; Shin HY; Kim SM; Sunwoo IN; Suh BC; Choi YC J Korean Med Sci; 2012 Apr; 27(4):423-9. PubMed ID: 22468107 [TBL] [Abstract][Full Text] [Related]
36. Novel sequence variants in dysferlin-deficient muscular dystrophy leading to mRNA decay and possible C2-domain misfolding. Wenzel K; Carl M; Perrot A; Zabojszcza J; Assadi M; Ebeling M; Geier C; Robinson PN; Kress W; Osterziel KJ; Spuler S Hum Mutat; 2006 Jun; 27(6):599-600. PubMed ID: 16705711 [TBL] [Abstract][Full Text] [Related]
37. Limb-Girdle Muscular Dystrophy Type 2B (LGMD2B) caused by Pathogenic Splice and Missense Variants of Arab F; Ahangari N; Malek H; Doosti M; Najarzadeh Torbati P; Ghayoor Karimiani E Adv Biomed Res; 2023; 12():150. PubMed ID: 37564451 [TBL] [Abstract][Full Text] [Related]